Author

A. Neyret

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Organism:yeast· 1

Frequent Co-Authors

C. Chable-Bessia· 2 shared D. Muriaux· 2 shared M. Henaut· 2 shared N. Gros· 2 shared P. Merida· 2 shared S. Lyonnais· 2 shared A. Abrieu· 1 shared A. L. Chaves Valadao· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Chable-Bessia

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The kinesin Kip2 promotes microtubule growth using a bipartite polymerase module to deliver tubulin to microtubule plus-ends

S. Nadalis, A. Neyret, A. Abrieu, H. Drechsler, D. Liakopoulos, D. Portran

This study identifies the mechanism by which Kip2 promotes microtubule growth through a bipartite polymerase module that delivers tubulin to microtubule plus-ends.

bioRxiv · Jul 19, 2024Cell Biology

Human MX1 orchestrates the cytoplasmic sequestration of neo-synthesized influenza A virus vRNPs

J. McKellar, F. Garcia de Gracia, C. Aube, A. L. Chaves Valadao, M. Tauziet, M. Arnaud-Arnould, A. Rebendenne, A. Neyret, E. Labaronne, E. P. Ricci, B. Delaval, R. Gaudin, N. Naffakh, S. Gallois-Montbrun, O. Moncorge, C. Goujon

This study shows human MX1 restricts influenza A virus by sequestering vRNPs in cytoplasmic clusters via dynein and microtubules, reducing viral production.

bioRxiv · Feb 22, 2024 · PreprintMicrobiology

Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.

C. Chable-Bessia, C. Boulle, A. Neyret, J. M. Swain, M. Henaut, P. Merida, N. Gros, A. Makinson, S. Lyonnais, C. B. Chesnais, D. Muriaux

This study evaluates the anti-SARS-CoV-2 activity of ivermectin and other macrocyclic lactones in vitro, finding low selectivity indices that suggest limited therapeutic potential for COVID-19.

bioRxiv · Nov 1, 2021 · PreprintMicrobiology

Direct visualization of native infectious SARS-CoV-2 and its inactivation forms using high resolution Atomic Force Microscopy

S. Lyonnais, M. Henaut, A. Neyret, P. Merida, N. Gros, C. Chable-Bessia, D. Muriaux

This paper uses atomic force microscopy to visualize native and inactivated SARS-CoV-2 viruses, showing their structural changes after formaldehyde treatment.

bioRxiv · Oct 23, 2020 · PreprintMicrobiology